A recent FierceBiotech article discussed the FDA’s action to remove coronavirus antibody tests from the market. The agency ended its open-door policy on blood tests and now requires developers to submit their products and data for review. In total, the FDA is asking that 28 serology tests be pulled from the market including tests that were voluntarily withdrawn by their sponsors and others that never pursued official FDA Emergency Use Authorization. Test makers with active products were given 10 days to submit applications for review.
Quick Hits: FDA Cracks Down on Antibody Tests
The FDA listed 28 coronavirus antibody diagnostic tests that should be removed from the market.
May 28, 2020
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
